NEW YORK (TheStreet) -- CHANGE IN RATINGS
BP was upgraded to buy at TheStreet Ratings.
CVS Caremark was downgraded at Cantor Fitzgerald to hold from buy. Valuation call, based on a $62 price target, Cantor said.
Fiserv was upgraded at Sterne Agee to buy from neutral. $120 price target. Company should deliver higher internal sales growth this year, given better end-market conditions, Sterne Agee said.
Fossil was downgraded at Citigroup to neutral from buy. Based on valuation and despite global growth opportunity, said Citi. Price target goes to $135.
McDermott was downgraded at DA Davidson to neutral from buy. $7.25 price target. Losses are broadening, DA Davidson said.
Mead Johnson was upgraded at Credit Suisse to outperform from neutral. $90 price target. Company should benefit from competitor recalls, Credit Suisse said.
Marathon Oil was downgraded at Bank of America/Merrill Lynch to neutral. Valuation call, based on a $42 price target, BofA/Merrill said.
OneBeacon was downgraded to hold at TheStreet Ratings.
Yum! Brands was upgraded at Bank of America/Merrill Lynch to neutral from underperform. $79 price target. Market is more willing than expected to look through China issues, BofA/Merrill said.
Stock Comments / EPS Changes
AECOM Technology numbers were cut at UBS. Estimates were reduced as backlog conversion is taking longer than expected, said UBS. Price target is reduced to $33.
American International numbers were increased at BMO Capital. Estimates were raised through 2014. Business turnaround is on course, BMO Capital said. Outperform rating and new $55 price target.
BlackRock price target was raised at Citigroup to $285. The company remains on message with regard to positioning, organic growth, margins and capital returns, Citi said.
Charles River Laboratories price target was raised at Jefferies to $57. Company is a relative value with an improving outlook in a CRO sector with very high investor enthusiasm, Jefferies said. Buy rating.
Cisco Systems price target boosted at BMO Capital to $29. Expect strong earnings and guidance from the company on Aug. 14, BMO Capital said. Outperform rating.
Cognizant estimates were reduced at Citigroup. Higher revenue expectations were offset by taxes, said Citigroup. Price target is $90.
CVS Caremark estimates were reduced at UBS. Estimates were reduced given risk in individual and group Medicare Part D, said UBS. Price target is $64.
DISH Network estimates were cut at UBS. Increased competition and rising costs, said UBS. Price target is $50.
Denbury estimates were raised at UBS. Estimates were boosted as cost forecasts were lowered, said UBS. Price target is $18.
Endo numbers were raised at UBS. Estimates were raised with Qualitest on track, and cost efficiencies are achieved, said UBS. Price target goes to $43.
EOG Resources estimates were raised at Citigroup. Estimates were raised as production exceeded expectations and lower taxes, said Citi. Price target is bumped to $178.
Finisar numbers were raised at Jefferies. Price target was increased to $11.50. Estimates were also increased on positive first-quarter preannouncement driven by Datacom, Jefferies said. Underperform rating.
Fossil estimates, price target were increased at Oppenheimer. Estimates were raised through 2014. Europe and Asia are driving sales growth, Oppenheimer said. Perform rating and new $120 price target.
First Solar numbers were cut at UBS. Estimates were reduced as two projects were pushed out to 2014, said UBS. Price target goes to $48.
Hewlett-Packard numbers were raised at J.P. Morgan. Shares are now seen reaching $29. Estimates were also increased as business metrics could benefit from favorable revenue mix, J.P. Morgan said. Neutral rating.
Jazz numbers were raised at UBS. Estimates were raised to reflect a price increase in Xyrem and momentum in Erwinase, said UBS. Price target goes to $87.
Michael Kors numbers were increased at BMO Capital. Estimates were boosted through 2015. Company is seeing higher sales growth, BMO Capital said. Market Perform rating and new $72 price target.
La-Z-Boy numbers were boosted at Keybanc. Shares are now seen reaching $27. Estimates were also increased, as the company is gaining market share and is leveraged to a cyclical housing recovery, Keybanc said. Buy rating.
MGM Resorts numbers were raised at Lazard Capital Markets. Shares are now seen reaching $21. Company continues to cut costs in Las Vegas and Macau continues to ramp, Lazard Capital Markets said. Buy rating.
Nationstar Mortgage Holdings numbers were raised at Citigroup. Estimates were raised on improving originations, and the acquisition pipeline expands, said Citigroup. Price target is bumped to $52.
NetApp numbers were raised at J.P. Morgan. Shares are now seen reaching $45. Conversion rate of bookings improved in recent months, J.P. Morgan said. Overweight rating.
Nuance Communications numbers were reduced at UBS. Estimates were cut as the business transition is still uncertain. Price target goes to $22.
Regeneron estimates were raised at UBS. Estimates were raised based on new guidance and new focus on DME growth, said UBS. Price target is $290.
The Boston Beer Company price target was boosted at Citigroup to $222. Increased multiple given upbeat growth outlook, said Citigroup.
Vivus estimates were lowered at Jefferies through 2013. $5 price target. Weak second quarter but signs of acceleration in the third quarter. Underperform rating.
>To submit a news tip, email: firstname.lastname@example.org.
Follow TheStreet on Twitter and become a fan on Facebook.
EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.
- Investment & Company Information